These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22764573)

  • 21. Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients.
    Higgs BW; Zhu W; Richman L; Fiorentino DF; Greenberg SA; Jallal B; Yao Y
    Int J Rheum Dis; 2012 Feb; 15(1):25-35. PubMed ID: 22324944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine concentration in serum of lupus erythematosus patients: the effect on acute phase response.
    Lacki JK; Leszczynski P; Kelemen J; Müller W; Mackiewicz SH
    J Med; 1997; 28(1-2):99-107. PubMed ID: 9249616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The gene expression of type 17 T-helper cell-related cytokines in the urinary sediment of patients with systemic lupus erythematosus.
    Kwan BC; Tam LS; Lai KB; Lai FM; Li EK; Wang G; Chow KM; Li PK; Szeto CC
    Rheumatology (Oxford); 2009 Dec; 48(12):1491-7. PubMed ID: 19773408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased urinary interleukin 22 binding protein levels correlate with lupus nephritis activity.
    Yang X; Gao Y; Wang H; Zhao X; Gong X; Wang Q; Zhang X
    J Rheumatol; 2014 Sep; 41(9):1793-800. PubMed ID: 25086075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased serum levels of immunoglobulins, C-reactive protein, type 1 and type 2 cytokines in patients with mixed connective tissue disease.
    Bakri Hassan A; Rönnelid J; Gunnarsson I; Karlsson G; Berg L; Lundberg I
    J Autoimmun; 1998 Oct; 11(5):503-8. PubMed ID: 9802936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-17 in cutaneous lupus erythematosus.
    Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
    Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
    Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin D status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters.
    Bogaczewicz J; Sysa-Jedrzejowska A; Arkuszewska C; Zabek J; Kontny E; McCauliffe D; Wozniacka A
    Lupus; 2012 Apr; 21(5):477-84. PubMed ID: 22065093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
    Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG
    Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
    Enghard P; Langnickel D; Riemekasten G
    Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum milk fat globule epidermal growth factor 8 elevation may subdivide systemic lupus erythematosus into two pathophysiologically distinct subsets.
    Yamamoto N; Yamaguchi H; Ohmura K; Yokoyama T; Yoshifuji H; Yukawa N; Kawabata D; Fujii T; Morita S; Nagata S; Mimori T
    Lupus; 2014 Apr; 23(4):386-94. PubMed ID: 24554711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
    Svenungsson E; Gunnarsson I; Fei GZ; Lundberg IE; Klareskog L; Frostegård J
    Arthritis Rheum; 2003 Sep; 48(9):2533-40. PubMed ID: 13130473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum protein oxidation and apolipoprotein CIII levels in people with systemic lupus erythematosus with and without nephritis.
    Morgan PE; Sturgess AD; Hennessy A; Davies MJ
    Free Radic Res; 2007 Dec; 41(12):1301-12. PubMed ID: 17957542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of functional interleukin 10/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment.
    López P; Gómez J; Prado C; Gutiérrez C; Suárez A
    J Rheumatol; 2008 Aug; 35(8):1559-66. PubMed ID: 18597405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of acute physical exercise on cytokine levels in patients with systemic lupus erythematosus.
    da Silva AE; dos Reis-Neto ET; da Silva NP; Sato EI
    Lupus; 2013 Dec; 22(14):1479-83. PubMed ID: 24135080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fatigue in patients with systemic lupus erythematosus: lack of associations to serum cytokines, antiphospholipid antibodies, or other disease characteristics.
    Omdal R; Mellgren SI; Koldingsnes W; Jacobsen EA; Husby G
    J Rheumatol; 2002 Mar; 29(3):482-6. PubMed ID: 11908560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of immunosuppressive therapy on the messenger RNA expression of target genes in the urinary sediment of patients with active lupus nephritis.
    Chan RW; Lai FM; Li EK; Tam LS; Chow KM; Li PK; Szeto CC
    Nephrol Dial Transplant; 2006 Jun; 21(6):1534-40. PubMed ID: 16449281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus.
    Li J; Xie H; Wen T; Liu H; Zhu W; Chen X
    J Rheumatol; 2010 Apr; 37(4):766-75. PubMed ID: 20110525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High levels of TH2 cytokine gene expression in systemic lupus erythematosus.
    Richaud-Patin Y; Alcocer-Varela J; Llorente L
    Rev Invest Clin; 1995; 47(4):267-72. PubMed ID: 8525128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IFN-γ, CXCL16, uPAR: potential biomarkers for systemic lupus erythematosus.
    Wen S; He F; Zhu X; Yuan S; Liu H; Sun L
    Clin Exp Rheumatol; 2018; 36(1):36-43. PubMed ID: 28628472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.